Background Eisenmenger syndrome (ES) is a severe and fatal complication of uncorrected congenital heart disease characterised ...
Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...
Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite therapeutic advances, the disease-associated morbidity and mortality ...
Merck on Tuesday said its drug, Winrevair, met the primary endpoint in a Phase 2 study in adults with post- and precapillary pulmonary hypertension due to heart failure. The Rahway, N.J., ...
Key points A 53-year-old woman with rectosigmoid adenocarcinoma was seen in the radiation oncology clinic for her fifth and final fraction of neoadjuvant radiotherapy, where she reported chills, ...
Inhibikase will also grant underwriters a 30-day option to purchase up to about 10.3 million additional shares of its common stock at the public-offering price, minus discounts and commissions. The ...
Small-cell lung cancer makes up approximately 15 percent of lung cancers in the United States. The strongest risk factor for this cancer is smoking tobacco. Many people with small-cell lung cancer go ...
Stage 3 non-small cell lung cancer has spread to nearby tissues and lymph nodes but not to more distant tissues. Most people with this stage have lung cancer symptoms. Treatment can depend on several ...
High blood pressure (hypertension) causes thickening of the blood vessels and hardening of the arteries (arteriosclerosis). A study conducted by Brazilian researchers has shown for the first time that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback